Designing Strategic Formulation and Smart Drug Delivery Approaches
(The book will be published with an ISBN)
Submit chapter abstract (250-300 words) along with table of content to books.idaampublications@gmail.com
About The Book:
The book “Designing Strategic Formulation and Smart Drug Delivery Approaches” offers a concise yet insightful overview of modern pharmaceutical technologies. It covers advanced formulation techniques like targeted delivery, nanocarriers, in situ gels, and stimuli-responsive systems. Emphasizing Quality by Design (QbD), predictive modeling, and regulatory aspects, the book bridges scientific innovation with practical application. Aimed at postgraduates, researchers, and professionals, it highlights how strategic formulation can enhance bioavailability, address biological challenges, and improve patient care.
Tentative Table of Contents:
Part I: Foundations of Formulation and Design
Chapter 1:Fundamentals of Preformulation Studies(This chapter introduces the foundational concepts of pharmaceutics and preformulation. It covers drug- excipient compatibility, solubility, stability, and permeability assessments. Emphasis is placed on how preformulation studies shape rational formulation development).
- Chapter 2: Formulation Design and Optimization
(Covers the scientific principles behind designing pharmaceutical formulations. Discusses Design of Experiments (DoE), Quality by Design (QbD), risk assessment tools, and optimization strategies used to ensure product quality and performance).
Chapter 3:Concepts of Novel Drug Delivery Systems(Explores the evolution of drug delivery systems beyond conventional dosage forms. This chapter classifies and discusses controlled, targeted, and responsive systems, offering insight into formulation design for improved therapeutic outcomes).
Part II: Enabling Technologies and Enhancements
Chapter 4:Application of nanotechnology in Drug Delivery Systems(Focuses on nanocarriers like nanoparticles, liposomes, nanoemulsions, and dendrimers. Describes their design, targeting strategies, therapeutic advantages, challenges in scale-up, and regulatory considerations for nanomedicine products).
- Chapter 5: Advancements in Solubility Enhancement
(Discusses techniques to enhance the solubility and bioavailability of poorly water-soluble drugs. Includes solid dispersions, co-crystals, complexation, and novel carriers, along with polymer selection and characterization).
- Chapter 6: Self-Emulsifying Drug Delivery Systems (SEDDS and S-SMEDDS)
(This chapter delves into lipid-based systems, especially SEDDS and solid-SMEDDS, used for oral delivery of lipophilic drugs. It explains formulation strategies, mechanisms of self-emulsification, and factors affecting bioavailability).
Part III: Advanced Delivery Routes and Systems
- Chapter 7: Advanced Oral Delivery Systems
(Reviews modern approaches to oral and transdermal delivery, including mucoadhesive tablets, colon-targeted systems, Gastro retentive systems etc. Highlights patient-centric design and recent technologies in systemic delivery.).
- Chapter 8: Advances in Transdermal Delivery Systems
(Recent innovations in Transdermal Drug Delivery Systems (TDDS), focusing on overcoming skin barriers using technologies like microneedles, nanocarriers, and permeation enhancers. It highlights advances in formulation strategies, smart patches, and controlled-release mechanisms).
- Chapter 9: Injectable and Implantable Drug Delivery Systems
(Examines parenteral dosage forms, including long-acting injectables, biodegradable implants, and in situ forming gels. Discusses formulation, sterilization, release mechanisms, and clinical applications).
- Chapter 10: Advancements in Ocular and Nasal Drug Delivery System
(Explores innovative strategies for enhancing drug absorption and targeting through the eye and nasal routes. It covers novel carriers like nanoparticles, in situ gels, and mucoadhesive systems that overcome anatomical and physiological barriers).
- Chapter 11: Biopharmaceutical Considerations and Drug Targeting
(Focuses on the interplay between pharmacokinetics, pharmacodynamics, and formulation design. Covers active and passive targeting, drug carriers for specific organs or cells, and principles behind precision targeting).
Part IV: Industrial Applications and Future Outlook
- Chapter 12: Regulatory, Stability and Scale-Up Challenges
(Addresses the regulatory framework for new drug delivery systems, ICH stability guidelines, and the complexities of scaling up lab formulations to commercial production, including GMP and process validation requirements).
- Chapter 13: 3D Printing and Personalized Pharmaceutics
(Introduces the role of 3D printing in pharmaceutical manufacturing, enabling personalized drug delivery. Describes various printing techniques, their advantages, and challenges in regulatory approval and scalability).
- Chapter 14: Future Trends in Pharmaceutics and Precision Medicine
(Looks ahead at disruptive technologies shaping pharmaceutics, such as AI-driven formulation, smart materials, green technologies, and the integration of diagnostics and therapeutics in personalized medicine).
[Note: Strikethrough chapters (1, 3, 4) are already been taken by other authors].
About Editors:
Dr. Mrunali Potbhare
Professor,
Mauli Institute of Pharmacy & Research Center, Washim, Maharashtra, India
Dr. Deepak Khobragade
Professor and Dean Academics,
Datta Meghe College of Pharmacy, DMIHER (DU), Sawangi Meghe Wardha, Maharashtra
Dr. Surendra Agrawal
Professor,
Datta Meghe College of Pharmacy, DMIHER (DU), Sawangi Meghe Wardha, Maharashtra
Important Dates:
• Abstract Submission: by 10ᵗʰ August 2025
• Abstract Acceptance: by 15ᵗʰ August 2025
• Full Chapter Submission: by 31ˢᵗ October 2025
• Full Chapter Acceptance: by 10ᵗʰ November 2025
Chapter Processing Charge (CPC):
A Chapter Processing Charge (CPC) is required to cover the costs of typesetting, processing, and global online hosting. All corresponding authors will be asked to pay their publication charges upon acceptance of abstract as Chapter Processing Charge –
USD 100 (for overseas authors), INR 3000 (for authors from India) per published chapter (Maximum 3 Authors per Chapter).